Stirling mother says medicinal cannabis an ‘outrageous cost’
Michelle O'Brien (Stirling) with her son Caleb (13). MEDICINAL cannabis has substantially improved a Stirling teenager’s health but the extraordinary cost is putting it out of reach. Michelle O’Brien said her son Caleb Bhatti’s seizures have reduced from 10 a day to one a week since he started taking Canadian company Tilray’s cannabidiol (CBD) product, a non-psychoactive compound from cannabis. Caleb (13) was diagnosed with a brain tumour when he was eight months old, followed by an epilepsy diagnosis two months later.
He also has an intellectual disability and the tumour’s position makes it too risky to remove.